AMANDA PRIMOZICH: Open Payments
NPI 1902200405 · ROCHESTER HILLS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$390 in 21 payments from 9 companies in 2025. Trend: 2023 $662 · 2024 $586 · 2025 $390
Food & beverage: $390
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $160 |
| Exact Sciences Corporation | 3 | $63 |
| ABBVIE INC. | 3 | $50 |
| Esperion Therapeutics, Inc. | 2 | $28 |
| Corcept Therapeutics | 1 | $22 |
| SANOFI-AVENTIS U.S. LLC | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| ABIOMED | 1 | $17 |
| Seqirus USA Inc | 1 | $14 |
Products named: Ozempic, Wegovy, Cologuard Collection Kit, QULIPTA, NEXLETOL, Rybelsus, Korlym, TZIELD.
Industry payments across MI — which companies pay providers there.
